Pharma has, at times, had to build the plane while flying it amid tectonic shifts driven by artificial intelligence (AI) and emerging technologies, and a senior MSD executive underlined that industry needs to condense the technology adoption cycle to best capture the opportunity on hand.
MSD’s chief information and digital officer Dave Williams said at a recent conference there are probably hundreds or thousands of different tools, applications and platforms just in the AI and machine learning (ML) space, and the rate and pace of technological change is faster than he had seen in his 30-plus years in the segment. This is especially so in the last couple of years with the arrival of
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?